Gladius Capital Management’s Maravai LifeSciences MRVI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-6,159	Closed	-$53.4K	–	294
2024 Q1	$53.4K	Buy	6,159 +1,554	+34%	+$13.5K	0.02%	122
2023 Q4	$30.2K	Buy	+4,605	New	+$30.2K	﹤0.01%	205
2023 Q1	–	Sell	-2,608	Closed	-$37.3K	–	330
2022 Q4	$37.3K	Buy	+2,608	New	+$37.3K	﹤0.01%	192